CUSTOMER TECHNICAL SUPPORT EXPERIENCING HIGH CALL VOLUME. MORE >
Over the years the majority of our customers have chosen our 300-unit t:slim X2™ insulin pump and as a result, demand for the 480-unit t:flex® insulin pump has not been enough to support its continued development.
We are confident that those who are interested in the t:flex insulin pump will love our advanced t:slim X2 insulin pump with Basal-IQ technology.
Current t:flex insulin pump user?
Rest assured, we will continue to provide t:flex cartridges, compatible infusion sets, and our top-rated, 24/7 customer support for the entire length of your warranty.
t:flex User Guide
*If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
1. Dexcom G6 continuous glucose monitor (CGM) sold separately. Transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 Pump) and one consumer device (phone or tablet) at the same time.
2. Additional feature updates are not currently available for the t:slim X2 Insulin Pump with Basal-IQ Technology and are subject to future FDA approvals. A prescription and additional training may be required to access certain future software updates. Charges may apply.
Caution: Federal (USA) law restricts the t:slim X2 insulin pump and the t:slim X2 insulin pump with Basal-IQ technology to sale by or on the order of a physician. The t:slim X2 insulin pump with Basal-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible integrated continuous glucose monitor (iCGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings. The pump and the System are indicated for use in individuals 6 years of age and greater. The pump and the System are intended for single patient use. The pump and the System are indicated for use with NovoLog or Humalog U-100 insulin. The System is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Users of the pump and the System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. For additional important safety information, visit www.tandemdiabetes.com/safetyinfo.